BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 25158987)

  • 1. Venous thrombosis in von Willebrand disease as observed in one centre and as reported in the literature.
    Girolami A; Tasinato V; Sambado L; Peroni E; Casonato A
    Blood Coagul Fibrinolysis; 2015 Jan; 26(1):54-8. PubMed ID: 25158987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepant ratios of arterial vs. venous thrombosis in hemophilias A and B as compared to FVII deficiency.
    Girolami A; Berti de Marinis G; Bertozzi I; Peroni E; Tasinato V; Lombardi AM
    Eur J Haematol; 2013 Aug; 91(2):152-6. PubMed ID: 23621110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superficial and deep venous thrombosis, pulmonary embolism and subsequent risk of cancer.
    Sørensen HT; Sværke C; Farkas DK; Christiansen CF; Pedersen L; Lash TL; Prandoni P; Baron JA
    Eur J Cancer; 2012 Mar; 48(4):586-93. PubMed ID: 22129887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of deep vein thrombosis and pulmonary embolism in superficial thrombophlebitis of the lower limbs: prospective study of 60 cases.
    Sobreira ML; Maffei FH; Yoshida WB; Rollo HA; Lastória S; Griva BL; De Carvalho LR
    Int Angiol; 2009 Oct; 28(5):400-8. PubMed ID: 19935595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of hemostatic factors on the risk of venous thrombosis in people with impaired kidney function.
    Ocak G; Vossen CY; Lijfering WM; Verduijn M; Dekker FW; Rosendaal FR; Cannegieter SC
    Circulation; 2014 Feb; 129(6):683-91. PubMed ID: 24211824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance.
    Castaman G; Tosetto A; Federici AB; Rodeghiero F
    Thromb Haemost; 2011 Apr; 105(4):647-54. PubMed ID: 21264446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and diagnosis of thrombosis in children with short-term central venous lines of the upper venous system.
    Hanslik A; Thom K; Haumer M; Kitzmüller E; Albinni S; Wolfsberger M; Salzer-Muhar U; Male C
    Pediatrics; 2008 Dec; 122(6):1284-91. PubMed ID: 19047247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review.
    Girolami A; Ruzzon E; Tezza F; Scandellari R; Vettore S; Girolami B
    Haemophilia; 2006 Jul; 12(4):345-51. PubMed ID: 16834733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for mortality in patients with upper extremity and internal jugular deep venous thrombosis.
    Hingorani A; Ascher E; Markevich N; Yorkovich W; Schutzer R; Mutyala M; Nahata S; Jacob T
    J Vasc Surg; 2005 Mar; 41(3):476-8. PubMed ID: 15838483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thrombosis after long-haul flights.
    Schwarz T; Siegert G; Oettler W; Halbritter K; Beyer J; Frommhold R; Gehrisch S; Lenz F; Kuhlisch E; Schroeder HE; Schellong SM
    Arch Intern Med; 2003 Dec 8-22; 163(22):2759-64. PubMed ID: 14662630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymptomatic venous thrombosis in cancer patients--a problem often overlooked. Results of a retrospective and prospective study.
    Heidrich H; Konau E; Hesse P
    Vasa; 2009 May; 38(2):160-6. PubMed ID: 19588304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Asymptomatic thrombo-embolic venous disease before total hip replacement--when the risk is important?].
    Jabłoński M; Turzańska K; Gorzelak M; Posturzyńska A; Wójcik B; Pluta R
    Chir Narzadow Ruchu Ortop Pol; 2008; 73(6):381-5. PubMed ID: 19241887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of venous thrombosis incidence in patients with acute hyperthyroidism.
    Kim DD; Chunilal S; Young S; Cutfield R
    Intern Med J; 2013 Apr; 43(4):361-5. PubMed ID: 22758384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portal vein thrombosis - experience in a single centre.
    Swallow G; Pavord S
    Br J Haematol; 2012 Nov; 159(4):482-4. PubMed ID: 22957491
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of a rapid von Willebrand factor activity latex immuno assay for monitoring of patients with von Willebrand disease (VWD) receiving DDAVP or VWF replacement therapy.
    Vinayagam S; Simons LR; Chowdary P; Thurlow P; Brooks SV; Riddell AF
    Haemophilia; 2014 Jul; 20(4):e304-10. PubMed ID: 24758424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superficial venous thrombosis: prevalence of common genetic risk factors and their role on spreading to deep veins.
    Milio G; Siragusa S; Minà C; Amato C; Corrado E; Grimaudo S; Novo S
    Thromb Res; 2008; 123(2):194-9. PubMed ID: 18387654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant FVIIa concentrate-associated thrombotic events in congenital bleeding disorders other than hemophilias.
    Girolami A; de Marinis GB; Bonamigo E; Lombardi AM
    Hematology; 2012 Nov; 17(6):346-9. PubMed ID: 22980722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombosis in VonWillebrand disease.
    Qureshi W; Hassan S; Dabak V; Kuriakose P
    Thromb Res; 2012 Nov; 130(5):e255-8. PubMed ID: 22995530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute superficial thrombophlebitis--therapeutic strategies].
    Noppeney T; Noppeney J; Winkler M; Kurth I
    Zentralbl Chir; 2006 Feb; 131(1):51-6. PubMed ID: 16485211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin.
    Graf L; Moffat KA; Carlino SA; Chan AK; Iorio A; Giulivi A; Hayward CP
    Int J Lab Hematol; 2014 Jun; 36(3):341-51. PubMed ID: 24750681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.